NP / PA
Cheek, Lisa
Cheek, Lisa was paid $642K by Medicaid between Mar 2020 and Dec 2024, across 33 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoCHEEK, LISA
SALYERSVILLE, KY 41465
SALYERSVILLE, KY 41465
33aNPI1871059774assigned 02/15/2019
33bProvider typeFamily Nurse Practitioner
28Total paid$642K
24GClaims49,887
24DCodes billed33
24AFirst – last monthMar 2020 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Kentucky
Rank by total paid#38 of 424
Median peer was paid$19K
This provider vs. median34×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,004 | $14K | |
| 2021 | 1,165 | $13K | |
| 2022 | 11,494 | $130K | |
| 2023 | 15,340 | $201K | |
| 2024incomplete | 19,884 | $284K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 6,177 | 2,461 | $165K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 4,983 | 2,116 | $164K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 21% | 7,054 | 2,612 | $137K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 6.0% | 1,025 | 445 | $38K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4.2% | 1,093 | 395 | $27K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3.3% | 5,461 | 2,011 | $21K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 3.0% | 2,259 | 667 | $19K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1.8% | 7,034 | 2,240 | $12K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 301 | 237 | $9K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 1,043 | 379 | $8K |
| 99310 | Prolong nursin fac eval 15m | 1.1% | 724 | 279 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 350 | 242 | $6K |
21 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 471 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,232 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 461 | $3K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 54 | $3K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 45 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 287 | $3K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 15 | $1K |
| J1110 | Injection, dihydroergotamine mesylate, per 1 mg | <1% | 148 | $948.16 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 806 | $910.48 |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 186 | $794.00 |
| 81002 | <1% | 1,317 | $702.29 | |
| 82962 | <1% | 364 | $683.60 | |
| G0452 | Molecular pathology procedure; physician interpretation and report | <1% | 848 | $530.16 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 428 | $497.96 |
| 36415 | Collection of venous blood by venipuncture | <1% | 455 | $473.69 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 367 | $421.18 |
| 94664 | <1% | 214 | $417.56 | |
| J1956 | Injection, levofloxacin, 250 mg | <1% | 151 | $401.83 |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | <1% | 164 | $197.28 |
| 36410 | <1% | 332 | $43.75 | |
| J1836 | Injection, metronidazole, 10 mg | <1% | 38 | $0.98 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.